Pharmaceutical

WuXi Biologics and Medigene link on T cell engagers for cancer

Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.

Aug 11, 2024 - 04:00
WuXi Biologics and Medigene link on T cell engagers for cancer
Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.
Read the original article

Tags:

Previous Article

Gilead Sciences reports net income rise in Q2 2024

Next Article

How the GLP-1 receptor agonist market could hit $168bn by 2033

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Health care developers are impressed by Apple Vision Pro, but they aren’t diving head first

STAT+: Health care developers are impressed by Apple Vi...

Feb 7, 2024

STAT+: House panel takes first steps toward reining in hospitals with ‘site-neutral’ changes

STAT+: House panel takes first steps toward reining in ...

May 17, 2023

STAT+: Explaining Change Healthcare and the gravity of its cyberattack

STAT+: Explaining Change Healthcare and the gravity of ...

Mar 4, 2024